Circio Holding ASA: June 2022 company update
Oslo, Norway, 15 June 2023 – Circio Holding ASA (OSE: CRNA), a biotechnology company developing next generation RNA therapeutics, today provides a general company update, demonstrating substantial progress for the company’s circRNA platform development. “Over the recent months we have accelerated the development of our unique circular RNA platform. The transition into a dedicated circRNA technology company has now been completed, with the aim to fully capture the potential of our differentiated approach and early mover advantage in this exciting new therapeutic area. The prioritization